• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

READ THE DIARIES: Documents unveil Fauci’s thoughts on the lab-leak debate, mask doubts and testing failures

by July 28, 2026
written by July 28, 2026

Sen. Rand Paul, R-Ky., on Tuesday released the private diaries of Dr. Anthony Fauci, the controversial former director of the National Institute of Allergy and Infectious Diseases (NIAID) and chief government spokesperson during the COVID-19 pandemic.

The released documents show Fauci privately confronted possibilities about the virus’s origins that he publicly downplayed. On Jan. 31, 2020, he recorded that scientists considered deliberate insertion of the virus possible and agreed it required further expert review, despite later public recommendations suggesting the contrary.

He later privately questioned CDC and FDA competence, admitted officials had overstated mask ineffectiveness and repeatedly described testing and supply failures.

FAUCI’S NEWLY RELEASED COVID DIARIES REVEAL BIZARRE FIXATION ON FAME AS PANDEMIC DEATHS MOUNTED

Throughout his time as NIAID director, he made note of conversations, decisions and his thoughts about actions taken by politicians and other officials. What Paul released is Fauci’s historical record containing almost-daily entries.

“Later in the pandemic, he gloried in the positive attention he was receiving from legacy media and demonized those who questioned his official narrative — like me,” Paul said — alluding to heated exchanges during congressional hearings when Paul grilled Fauci over his pandemic response.

“Many entries in Fauci’s daily historical account completely undermine the official narrative that Fauci and other public health officials espoused,” Paul wrote in his introduction to the documents.

SLACK MESSAGES RELEASED BY RAND PAUL APPEAR TO SHOW AUTHORS OF KEY COVID-19 ORIGIN PAPER HELD PRIVATE DOUBTS

SIGN UP TO GET THE POLITICS NEWSLETTER

Paul said the “first alarm” went straight to the octogenarian immunologist, as he and two other medical experts examined the furin cleavage site in the virus and deliberated about the aforementioned genomic insertion and whether it truly escaped from a Chinese lab.

“Before most Americans knew there was an origins debate, the government’s top infectious-disease official was already confronting the lab scenario,” Paul said.

This post appeared first on https://www.foxnews.com

0 comment
0
FacebookTwitterPinterestEmail

previous post
EXCLUSIVE: Biden pardon won’t shield Fauci if he lies to Congress, Comer says

related articles

Acting DNI touts ‘approximately 30% Staff Reduction from...

July 28, 2026

DEI hiring boost for one blue state’s Muslim...

July 28, 2026

EXCLUSIVE: Biden pardon won’t shield Fauci if he...

July 28, 2026

Prominent Holocaust museum challenges Mamdani with offer in...

July 28, 2026

Far-left Senate hopeful explains ‘ogre on a pike’...

July 28, 2026

Russia exposes NATO weapons gap as top commander...

July 28, 2026

Republican and Democratic coalitions put to the test...

July 28, 2026

Democrats target more GOP House seats after socialist...

July 28, 2026

Biden’s Hur interview tapes could now go public...

July 27, 2026

Trump demands Thune keep Senate in session until...

July 27, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • 4 AI infrastructure stocks flying under the radar in 2026

    June 24, 2026
  • Qualcomm stock rises on AI chip push, Tenstorrent deal speculation

    June 16, 2026
  • Trump Iran framework gambles on diplomacy despite warning Tehran will ‘lie and cheat’

    June 18, 2026
  • Mamdani-backed socialist prevails in crowded primary to replace retiring rep

    June 24, 2026
  • Dem Rhode Island lawmaker threatens ICE: ‘Your day of reckoning will come m—– f——‘

    July 23, 2026

Popular Posts

  • 1

    CoreWeave stock jumps 10% as analysts see major backlog upside

    June 16, 2026
  • 2

    Dow tumbles 680 points as chip rout sends Nasdaq to biggest drop since 2025

    June 5, 2026
  • 3

    Intel, AMD stocks slide again in aftermath of Broadcom’s weak outlook

    June 5, 2026
  • 4

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026
  • 5

    Wedbush makes a strong case for buying the dip in Planet Labs stock

    June 5, 2026

Categories

  • Editor's Pick (344)
  • Investing (944)
  • Stock (38)

Latest Posts

  • Soaring Astera Labs stock faces a major valuation risk: what next?

    June 9, 2026
  • Tesla slips as SpaceX debuts: Buy SPCX or buy the TSLA dip?

    June 12, 2026
  • UK regulator tightens focus on Apple and Google’s app store ecosystem

    June 30, 2026

Recent Posts

  • S&P 500, SPY, VOO, IVV outlook: top news to watch this week

    June 14, 2026
  • TeraWulf stock surges as Anthropic signs $19B AI data center lease

    July 6, 2026
  • Josh Brown recommends sticking with these three winning stocks

    June 23, 2026

Editor’s Pick

  • Broadcom stock’s latest catalyst targets Nvidia where it looks strongest

    July 10, 2026
  • QuantumScape stock: what could trigger its looming 15% earnings swing?

    July 20, 2026
  • Oracle stock drops 3% as earnings test AI growth narrative

    June 10, 2026
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock